Abstract
Surgical site infection (SSI) is an important and serious problem of surgery considering increase in rates of mortality and morbidity, hospitalization period and healthcare costs. The suture materials, which are among the surgical risk factors providing a basis for development of these infections is an issue, which inevitably requires consideration. Suture materials are used for restoring tissue integrity, which is adversely influenced from the surgical procedure, and for controlling bleeding that occurs during surgery and they are among the most commonly used materials by the surgical team. This issue has been discussed in studies published since '50s that these materials lead to infections. Due to the advances in the technology, suture materials coated with triclosan, an antibacterial agent, for preventing SSIs are introduced. Whether antibacterial suture materials minimize the occurrence of infection by preventing growth of MRSA and Staphylococcus epidermidis or do they have any contribution to prevention of infections is discussed in various clinical and in vitro studies conducted on these materials, but the number of such studies is limited. Although it is difficult to determine the risk factors of a multi-variable environment related with the patient and the surgical process, removal of the risk of infection originating from these materials during the surgical interventions and use of best suitable materials in the patient are among the most significant duties of the surgical team. The effects of antibacterial suture materials on prevention of SSI are discussed in this study, with regard to the recent literature.
Keywords: Surgical site infections, suture materials, antibacterial suture materials
References
Barbaros U, Bozbora A. Cerrahi Alan İnfeksiyonları, Türkiye Klinikleri J Surg Med Sci 2006; 2:14-15.
Şelimen D. Dikiş materyalleri ve bakteri tutma özelliklerine bir bakış. Kartal Devlet Hastanesi Tıp Dergisi 1990;1:189-190.
Köhle Ü, Demir CY. Oftalmik cerrahide sütür materyalleri. İnönü Üniversitesi Tıp Fakültesi Dergisi 2003; 10: 217-221.
Coşkun F, Düzgün AP. Sütür materyalleri ve cerrahi düğümler, (Ed: Necmi Kurt), Akut ve Kronik Yara Bakımı, Nobel Tıp Evi; 1.Baskı, 2003. p.100-123.
James RC, Mac Leod CJ. Induction of staphylococcal infections in mice with small inocula introduced on sutures. Br J Exp Pathol 1961; 42:266-272.
Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures. A possible factor in suture induced infection. Ann Surg 1982;194:35-41.
Williams DF. The reactions of tissues to materials. Bio Med Eng 1971; 17:152-177.
Elek SD, Conen PE. The virulence of Staphylococcus pyogenes for man a study of the problem of wound infection. Br J Exp Pathol 1957; 38: 573-579.
Köksal C, Bozkurt K, Arslan C, İlvan Ş, Özkaynak B, Öz B ve ark. Değişik dikiş materyallerinin sıçan aortasında oluşturdukları histopatolojik değişiklikler. GKDC Dergisi 1999; 7: 130-134.
Edlich RF, Panek PH, Rodeheaver GT, Kurtz LD, Edgerton MT. Surgical sutures and infection: A biomaterial evaluation. J Biomed Materials Res 2004; 8: 115- 126.
Hochberg J, Meyer KM, Marion M. Suture choice and other methods of skin closure. Surg Clin N Am 2009; 89: 627-641. DOI:10.1016/j.suc.2009.03.001
Storch M, Perry L, Davidson JM, Ward JJ. A 28- day study of the effect of coated Vicryl Plus antibacterial suture (coated polyglactin 910 with triclosan) on wound healing in guinea pig linear incisional skin wounds. Surg Infect 2002; 3: 89-98. DOI:10.1089/10962960260496370
Barbolt TA. Chemistry and safety of triclosan, and its use as an antimicrobial coating on coated VICRYL Plus antibacterial suture (Coated Polyglatin 910 Suture with triclosan), Surgical Infect 2002; 3:45-53. DOI:10.1089/10962960260496334
Rothenburger S, Spangler D, Shubhangi B, Burkley D. In vitro antimicrobial evaluation of coated Vicrly Plus antibacterial suture using zone of inhibition assays. Surg Infect 2003; 3: 79-87.
Gomez – Alonso A, Garcia- Criado FC, Parreno- Manchado FJ. Study of the efficacy of coated Vicryl Plus antibacterial suture in two animal models of general surgery. J Infect 2007; 54:82-88.
Singer H, Muller S, Tixier C, Pillonel L. Triclosan: occurrence and fate of a widely used biocide in the aquatic environment: field measurements in wastewater treatment plants, surface waters and lake sediments. Environ Sci Technol 2002; 36: 4998-5004. DOI:10.1021/es025750i
Russel AD. Similarities and differences in the responses of microorganizms to biocides. J Antimicrobial Chemother 2003; 52: 750-763. a
Schmid MB, Kaplan N. Reduced triclosan susceptibility in methicillin- resistance by chronic triclosan exposure is not universal. J Antimicrobial Chemother 2004; 53:772-773. DOI:10.1128/AAC.48.4.1397- 1399.2004
Heath RJ, Rubin JR, Holland DR, Zhangi E, Snow ME, Rock CO. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 1999;274:11110- 11114.
Radosti SC, Alee GV, Greenwood R, Nicholas R, Keller PM, DeWolf WE et al. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus. J Antimicrobial Chemother 2001; 48:1-6.
Fan F, Yan K, Wallis NG, Reed S, Moore TD, Rittenhouse SF et al. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:3343-3347. DOI:10.1128/ AAC.46.11.3343-3347.2002
Schweizer HP. Triclosan: a widely used biocide and its link to antibiotics, FEMS Microbiology Letters 2001; 202: 1-7. DOI:10.1016/S0378-1097(01)00273-7
Fleck T, Moidl R, Balcky A, Fleck M, Wolner E, Grabenwoger M et al. Triclosan- coated suture for the reduction of sternal wound infections: Economic considerations, Ann Thoracic Surg 2007; 84: 232- 236. DOI:10.1016/j.athoracsur. 2007.03.045
Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD et al. Bacterial adherence to surgical sutures: Can antibacterial- coated sutures reduce the risk of microbial contamination? J Am Coll Surg 2006;203;481- 489.
Justinger C, Moussavian MR, Schlueter C, Kopp B, Kollmar O, Schilling MK. Antibiotic coating of abdominal closure sutures and wound infection, Surgery 2009;145:330-334.
Leonardo J, Rozelle CJ. Antimicrobial suture use associated with a decreased incidence of cerebrospinal fluid shunt infections. Neurosurgery 2006; 5:478-482. DOI:10.1227/00006123-200608000-00110
Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective double-blinded, randomized controlled trial. J Neorosurg Pediatr 2008;2: 109- 110.
Ford HR, Jones P, Gaines B, Reblock K, Simpkins DL. Intraoperative handling and wound healing: Controlled clinical trial comparing coated VICRYL plus antibacterial suture (Coated polyglactin 910 suture with triclosan) with coated VICRYL suture (Coated polyglactin 910 suture). Surg Infect 2005;6:313-321. DOI:10.1089/sur.2005.6.313
Mingmalairak C, Ungbhakorn P, Paocharoen V. Efficacy of antimicrobial coating suture coated polyglactin 910 with triclosan (Vicryl Plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis. Double blind randomized control trial, preliminary safety report. J Med Assoc Thai 2009; 9s2: 770-775.
Deliaert AE, Kerchove EV, Tuinder S, Fieuws S, Sawor JH, Meesters-Caberg MA et al. The effect of triclosan-coated suture in wound healing. A double blind randomized prospective pilot study. J Plast Reconstr Aesthet Surg 2009; 62: 771- 773.
